Find Mepifiline manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mepifylline, Mepyramine theophylline acetate, 57383-74-1, 20hd67185n, 7h-purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, compd. with n-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-1,2-ethanediamine (1:1), Mepiphylline
Molecular Formula
C26H33N7O5
Molecular Weight
523.6  g/mol
InChI Key
TXBZJCTVHPHWPH-UHFFFAOYSA-N
FDA UNII
20HD67185N

Mepifiline
1 2D Structure

Mepifiline

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid;N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine
2.1.2 InChI
InChI=1S/C17H23N3O.C9H10N4O4/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15;1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4-11H,12-14H2,1-3H3;4H,3H2,1-2H3,(H,14,15)
2.1.3 InChI Key
TXBZJCTVHPHWPH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
2.2 Other Identifiers
2.2.1 UNII
20HD67185N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Fluidasa

2. Ma 27.110

3. Made 27.110

4. Mepiphylline

5. Mepyramine 7-theophyllineacetate

6. Mepyramine-theophylline-acetate

2.3.2 Depositor-Supplied Synonyms

1. Mepifylline

2. Mepyramine Theophylline Acetate

3. 57383-74-1

4. 20hd67185n

5. 7h-purine-7-acetic Acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, Compd. With N-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-1,2-ethanediamine (1:1)

6. Mepiphylline

7. Einecs 260-716-6

8. Mepyramine 7-theophyllineacetate

9. Unii-20hd67185n

10. Fluidasa (tn)

11. Mepyramine Theophyllineacetate

12. Mepiphylline [who-dd]

13. Schembl11824343

14. Dtxsid60205978

15. Made-27110

16. 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetic Acid,compound With N-(p-methoxybenzyl)-n',n'-dimethyl-n-(2-pyridyl)eth Ane-1,2-diamine (1:1)

17. D08184

18. Q27253461

19. 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetic Acid N-(p-methoxybenzyl)-n',n'-dimethyl-n-(2-pyridyl)ethane-1,2-diamine

20. 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic Acid;n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 523.6 g/mol
Molecular Formula C26H33N7O5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass523.25431718 g/mol
Monoisotopic Mass523.25431718 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count38
Formal Charge0
Complexity662
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty